These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12798838)

  • 1. Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care?
    Ledwidge M; Barry M; Cahill J; Ryan E; Maurer B; Ryder M; Travers B; Timmons L; McDonald K
    Eur J Heart Fail; 2003 Jun; 5(3):381-9. PubMed ID: 12798838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing.
    Andersson F; Cline C; Rydén-Bergsten T; Erhardt L
    Pharmacoeconomics; 1999 Jun; 15(6):535-50. PubMed ID: 10538327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) study.
    Ledwidge MT; O'Connell E; Gallagher J; Tilson L; James S; Voon V; Bermingham M; Tallon E; Watson C; O'Hanlon R; Barry M; McDonald K
    Eur J Heart Fail; 2015 Jul; 17(7):672-9. PubMed ID: 26139583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new programme of multidisciplinary care for patients with heart failure in Poznań: one-year follow-up.
    Wierzchowiecki M; Poprawski K; Nowicka A; Kandziora M; Piatkowska A; Jankowiak M; Michałowicz B; Stawski W; Dziamska M; Kaszuba D; Szymanowska K; Michalski M
    Kardiol Pol; 2006 Oct; 64(10):1063-70; discussion 1071-2. PubMed ID: 17089238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure management: multidisciplinary care has intrinsic benefit above the optimization of medical care.
    McDonald K; Ledwidge M; Cahill J; Quigley P; Maurer B; Travers B; Ryder M; Kieran E; Timmons L; Ryan E
    J Card Fail; 2002 Jun; 8(3):142-8. PubMed ID: 12140806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-converting enzyme inhibitor dose at discharge.
    McDonald K; Ledwidge M; Cahill J; Kelly J; Quigley P; Maurer B; Begley F; Ryder M; Travers B; Timmons L; Burke T
    Eur J Heart Fail; 2001 Mar; 3(2):209-15. PubMed ID: 11246059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care.
    Capomolla S; Febo O; Ceresa M; Caporotondi A; Guazzotti G; La Rovere M; Ferrari M; Lenta F; Baldin S; Vaccarini C; Gnemmi M; Pinna G; Maestri R; Abelli P; Verdirosi S; Cobelli F
    J Am Coll Cardiol; 2002 Oct; 40(7):1259-66. PubMed ID: 12383573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost effectiveness of ACE inhibition in therapy of chronic heart failure in Switzerland: evaluation based on the SOLVD study].
    Szucs TD; Goedde M; Berger K; Kiowski W
    Schweiz Med Wochenschr; 1997 Jul; 127(29-30):1234-41. PubMed ID: 9333933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
    Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure. A decision analytic analysis of New Zealand data using the published results of the SOLVD Treatment Trial. Studies of Left Ventricular Dysfunction.
    Scott WG; Scott HM
    Pharmacoeconomics; 1996 Feb; 9(2):156-67. PubMed ID: 10160094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-modifying therapy and hospitalization risk in heart failure patients.
    Shaya FT; Breunig IM; Mehra MR
    Am J Manag Care; 2015 Jan; 21(1):39-47. PubMed ID: 25880149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers-based personalized follow-up in chronic heart failure improves patient's outcomes and reduces care associate cost.
    Leon-Justel A; Morgado Garcia-Polavieja JI; Alvarez-Rios AI; Caro Fernandez FJ; Merino PAP; Galvez Rios E; Vazquez-Rico I; Diaz Fernandez JF
    Health Qual Life Outcomes; 2021 May; 19(1):142. PubMed ID: 33964944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aggressive diuresis for severe heart failure in the elderly.
    Howard PA; Dunn MI
    Chest; 2001 Mar; 119(3):807-10. PubMed ID: 11243961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs.
    Skrepnek GH; Abarca J; Malone DC; Armstrong EP; Shirazi FM; Woosley RL
    Ann Pharmacother; 2005 Nov; 39(11):1785-91. PubMed ID: 16219900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial.
    Calvert MJ; Freemantle N; Yao G; Cleland JG; Billingham L; Daubert JC; Bryan S;
    Eur Heart J; 2005 Dec; 26(24):2681-8. PubMed ID: 16284203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose lisinopril in heart failure: economic considerations.
    Ess SM; Lüscher TF; Szucs TD
    Cardiovasc Drugs Ther; 2002 Jul; 16(4):365-71. PubMed ID: 12652106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost of inpatient management of heart failure patients: a microcosting study in the Irish healthcare setting.
    Morgan RB; McCullagh L; Barry M; Daly C
    Ir J Med Sci; 2017 May; 186(2):293-303. PubMed ID: 27864782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer-Alkmaar heart failure study.
    de la Porte PW; Lok DJ; van Veldhuisen DJ; van Wijngaarden J; Cornel JH; Zuithoff NP; Badings E; Hoes AW
    Heart; 2007 Jul; 93(7):819-25. PubMed ID: 17065182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of home versus clinic-based management of chronic heart failure: Extended follow-up of a pragmatic, multicentre randomized trial cohort - The WHICH? study (Which Heart Failure Intervention Is Most Cost-Effective & Consumer Friendly in Reducing Hospital Care).
    Maru S; Byrnes J; Carrington MJ; Chan YK; Thompson DR; Stewart S; Scuffham PA;
    Int J Cardiol; 2015 Dec; 201():368-75. PubMed ID: 26310979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Ambulatory, High-Dose, Intravenous Diuretic Therapy to Standard Hospitalization and Diuretic Therapy for Treatment of Acute Decompensated Heart Failure.
    Buckley LF; Seoane-Vazquez E; Cheng JW; Aldemerdash A; Cooper IM; Matta L; Medina DS; Mehra MR; Navarro-Velez K; Shea EL; Weintraub JR; Stevenson LW; Desai AS
    Am J Cardiol; 2016 Nov; 118(9):1350-1355. PubMed ID: 27772698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.